Goldman Sachs Reportedly Selected to Lead SpaceX IPO in Potential Landmark Market Debut Federal Reserves Path to Rate Cuts Narrowing Amid Persistent Cost of Living Pressures AMD Expanding Taiwan Production Capacity Amid Tightening Global CPU Supply UK Heatwave and Bank Holiday Travel Chaos May Impact Hospitality and Retail Sectors US Retail Sales Data Indicates Consumer Resilience Amid Persistent Cost Pressures UK PublicSector Pension Funding Under Scrutiny Amid Intergenerational Debate LightPath Technologies Q1 2026 Earnings EPS Misses Estimates Yet Stock Surges 187 MPLX Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds NextDecade Corporation Q1 2026 Earnings Narrower Loss Drives Modest Share Gain UCTT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction ALXO Q1 2026 Earnings NarrowerthanExpected Loss per Share Mirrors ClinicalStage Focus CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue Bank of the James Financial Group Inc BOTJ Edges Lower Amid Light Trading Support Levels in Focus Revolve Group RVLV Edges Higher Amid Sector Momentum Key Levels to Watch Arrow Financial Corporation AROW Edges Higher as Bullish Momentum Builds Johnson Johnson JNJ Edges Higher Amid Steady Trading Key Levels in Focus SPX Technologies SPXC Holds Near 208 After Modest Gain Key Resistance in Sight London Stock Exchange Group Reports Income Growth Driven by Tradeweb NiSource NI Q1 2026 Earnings EPS Falls Short But Stock Gains on Operational Resilience Palantir Technologies PLTR Dips 2 Support and Resistance Levels in Focus Columbus McKinnon CMCO Slips 15 as Selling Pressure Persists Near Key Support Levels A SPAC III Acquisition Corp ASPC Holds Steady at 1085 as Investors Await Business Combination Iveda Solutions Warrant IVDAW Holds Steady at 003 A Study in Stability Duluth Holdings DLTH Nears Support After Slight Decline Blackstone Strategic Credit 2027 Term Fund BGB Holds Steady at 1134 as Market Waits for Catalysts Lakeland Financial LKFN Holds Steady Near Support as Consolidation Continues Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867